NIH-funded research NIH-funded research

Center for Identification and Study of People with Atypical Diabetes

Official title: Center for Identification and Study of Individuals with Atypical Diabetes Mellitus

Funded at University of Chicago · NIH-11532339 · Data updated 2026-11-12

A research program at a major university aims to map and understand unusual forms of diabetes that don’t fit the common Type 1 or Type 2 categories, to improve diagnosis and care.

More Diabetes research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 10, 2018
Project endMay 31, 2029
Funding year2026
Award (this year)$164,000
NIH project number3U54DK118612-08S1
Project IDNIH-11532339 on NIH RePORTER

Who could benefit from this research

Could help

Adults with or suspected to have atypical or non-classic forms of diabetes, including those not fitting Type 1 or Type 2 categories, and their family members.

Less likely to help

Individuals with clearly classic Type 1 or Type 2 diabetes without atypical features may not directly benefit.

What this research studies

This NIH center brings together experts to find people with atypical diabetes, collect genetic and molecular data, and study how these forms develop. Researchers will sequence genomes, analyze RNA and metabolites, and use patient-derived stem cells to explore disease mechanisms. The goal is to identify distinct subtypes and pathways so that future treatments can be more precisely tailored to individuals with these unusual forms of diabetes. The project builds on an established network that already enrolls participants and characterizes them in depth, with plans to recruit more to expand understanding and improve classification. Participation may involve genetic testing, blood and tissue samples, and comprehensive phenotyping, all conducted with careful oversight and informed consent.

Why it matters

Potential benefit: Better diagnosis and personalized treatment options for people with atypical diabetes.

How similar studies have gone: Previous work has shown that deep molecular profiling can reveal distinct diabetes subtypes and inform future therapies.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Philipson, Louis H. — University of Chicago
  • Study coordinator: Philipson, Louis H.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.